医学
纤维蛋白
血栓
纸牌密码算法
内弹性层
外膜
管腔(解剖学)
支架
神经血管束
闭塞
纤溶
解剖
动脉
外科
内科学
缺血
改良兰金量表
免疫学
缺血性中风
作者
Gaurav Girdhar,Evan Epstein,Kevin Nguyen,Chelsea L. Gregg,Tejashri Kumar,J Wainwright,Amon Y. Liu,Italo Linfante
摘要
First pass success (FPS) can be defined as in vitro retrieval of clot in a single pass during mechanical thrombectomy (MT) for acute large vessel occlusion (LVO). Despite advancements in MT technology, retrieval of fibrin-rich clots remains a challenge. Therefore, the effect of stent retriever length on FPS for fibrin-rich clots was investigated by using Solitaire<sup>TM</sup> 6 × 40 versus 6 × 30 mm devices with a balloon guide catheter (BGC) or distal access catheter (DAC) and sheath, in an in vitro model of anterior circulation neurovascular anatomy. Additionally, vascular safety of the Solitaire<sup>TM</sup> 6 × 40 versus 6 × 30 mm devices was evaluated in a porcine model for differences in: luminal thrombus, inflammation, endothelial coverage, fibrin deposits, smooth muscle cell loss, elastic lamina and adventitia disruption, intimal hyperplasia, and lumen reduction, at 0, 30, and 90 days post-treatment. In vitro overall FPS was measured as: Solitaire<sup>TM</sup> 6 × 40 (95%) and Solitaire<sup>TM</sup> 6 × 30 (67%). FPS for clot location in middle cerebral artery was: (a) BGC (6 × 40 mm: 100%; 6 × 30 mm: 100%; <i>n</i> = 8); (b) DAC with 088 sheath (6 × 40 mm: 83%; 6 × 30 mm: 33%; <i>n</i> = 12). FPS for clot location in internal carotid artery was: (a) BGC (6 × 40 mm: 100%; 6 × 30 mm: 80%; <i>n</i> = 11); (b) DAC with 088 sheath (6 × 40 mm: 100%; 6 × 30 mm: 67%; <i>n</i> = 10). Stent length had a significant effect (Fisher’s exact test; <i>p</i> < 0.05) on FPS. In vivo evaluation in the porcine model showed no difference in vascular safety parameters between the Solitaire<sup>TM</sup> 6 × 40 and 6 × 30 mm devices (<i>p</i> > 0.05) at all time points in the study. Longer stent retrievers may be safe and effective in improving FPS for fibrin-rich clots in in vitro and in vivo models of LVO.
科研通智能强力驱动
Strongly Powered by AbleSci AI